Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Ulrich

Showing results (181-190 of 220) with videos related to

Pageof 22
Sort By:
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 12, 2020
The influence of endplate (Modic) changes on clinical outcomes in lumbar spinal stenosis surgery: a Swiss prospective multicenter cohort studyNils H Ulrich, Jakob M Burgstaller, Isaac Gravestock, et al.
Spine|March 25, 2020
Evaluating the Minimal Clinically Important Difference of EQ-5D-3L in Patients With Degenerative Lumbar Spinal Stenosis: A Swiss Prospective Multicenter Cohort StudyJakob M Burgstaller, Maria M Wertli, Nils H Ulrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.
Molecular Psychiatry|September 27, 2017
Purinergic system in psychiatric diseasesA Cheffer, A R G Castillo, J Corrêa-Velloso, et al.
Biochemical Pharmacology|December 28, 2010
Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B₂and M1 muscarinic acetylcholine receptorsK L P Morais, M A F Hayashi, F M Bruni, et al.
Neurosurgical Review|May 8, 2014
Brainstem cavernoma surgery with the support of pre- and postoperative diffusion tensor imaging: initial experiences and clinical course of 23 patientsNils H Ulrich, Ralf A Kockro, David Bellut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapyH Ulrich-Pur, G V Kornek, W Fiebiger, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 17, 1986
Auxin-regulated gene expressionJ L Key, P Kroner, J Walker, et al.
Onkologie|September 17, 2002
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination RegimenB Schüll, G V Kornek, K Schmid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerM Penz, G V Kornek, M Raderer, et al.
Pageof 22

Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
European Spine Journal : Official Publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society|March 12, 2020
The influence of endplate (Modic) changes on clinical outcomes in lumbar spinal stenosis surgery: a Swiss prospective multicenter cohort studyNils H Ulrich, Jakob M Burgstaller, Isaac Gravestock, et al.
Spine|March 25, 2020
Evaluating the Minimal Clinically Important Difference of EQ-5D-3L in Patients With Degenerative Lumbar Spinal Stenosis: A Swiss Prospective Multicenter Cohort StudyJakob M Burgstaller, Maria M Wertli, Nils H Ulrich, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapyW Scheithauer, G V Kornek, B Schuell, et al.
Molecular Psychiatry|September 27, 2017
Purinergic system in psychiatric diseasesA Cheffer, A R G Castillo, J Corrêa-Velloso, et al.
Biochemical Pharmacology|December 28, 2010
Bj-PRO-5a, a natural angiotensin-converting enzyme inhibitor, promotes vasodilatation mediated by both bradykinin B₂and M1 muscarinic acetylcholine receptorsK L P Morais, M A F Hayashi, F M Bruni, et al.
Neurosurgical Review|May 8, 2014
Brainstem cavernoma surgery with the support of pre- and postoperative diffusion tensor imaging: initial experiences and clinical course of 23 patientsNils H Ulrich, Ralf A Kockro, David Bellut, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 8, 2001
Multicenter phase II trial of dose-fractionated irinotecan in patients with advanced colorectal cancer failing oxaliplatin-based first-line combination chemotherapyH Ulrich-Pur, G V Kornek, W Fiebiger, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 17, 1986
Auxin-regulated gene expressionJ L Key, P Kroner, J Walker, et al.
Onkologie|September 17, 2002
Second-Line Treatment of Advanced Colorectal Cancer with a Biweekly Oxaliplatin plus Irinotecan Combination RegimenB Schüll, G V Kornek, K Schmid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Phase II trial of two-weekly gemcitabine in patients with advanced biliary tract cancerM Penz, G V Kornek, M Raderer, et al.
Pageof 22